MOSAPRIDE: 209 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
209
Total FAERS Reports
25 (12.0%)
Deaths Reported
114
Hospitalizations
209
As Primary/Secondary Suspect
15
Life-Threatening
3
Disabilities
Active Ingredient: MOSAPRIDE CITRATE ·
First Report: 20040729 · Latest Report: 20250605
What Are the Most Common MOSAPRIDE Side Effects?
#1 Most Reported
Hepatic function abnormal
23 reports (11.0%)
#2 Most Reported
Off label use
13 reports (6.2%)
#3 Most Reported
Nausea
13 reports (6.2%)
All MOSAPRIDE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Hepatic function abnormal | 23 | 11.0% | 2 | 15 |
| Nausea | 13 | 6.2% | 0 | 10 |
| Off label use | 13 | 6.2% | 4 | 8 |
| Diarrhoea | 12 | 5.7% | 2 | 8 |
| Drug-induced liver injury | 12 | 5.7% | 1 | 6 |
| Vomiting | 12 | 5.7% | 2 | 8 |
| Pyrexia | 11 | 5.3% | 0 | 7 |
| Stevens-johnson syndrome | 10 | 4.8% | 1 | 5 |
| Dizziness | 8 | 3.8% | 1 | 6 |
| Drug interaction | 8 | 3.8% | 0 | 4 |
| Erythema | 8 | 3.8% | 1 | 3 |
| Toxicity to various agents | 8 | 3.8% | 2 | 6 |
| Altered state of consciousness | 7 | 3.4% | 0 | 7 |
| Dehydration | 7 | 3.4% | 3 | 4 |
| Platelet count decreased | 7 | 3.4% | 3 | 4 |
| Pneumonia | 7 | 3.4% | 3 | 5 |
| Pruritus | 7 | 3.4% | 1 | 2 |
| Toxic epidermal necrolysis | 7 | 3.4% | 0 | 3 |
| Abdominal distension | 6 | 2.9% | 0 | 2 |
| Alanine aminotransferase increased | 6 | 2.9% | 1 | 2 |
Who Reports MOSAPRIDE Side Effects? Age & Gender Data
Gender: 53.0% female, 47.0% male. Average age: 64.3 years. Most reports from: JP. View detailed demographics →
Is MOSAPRIDE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2004 | 1 | 1 | 0 |
| 2010 | 2 | 0 | 1 |
| 2012 | 6 | 0 | 5 |
| 2013 | 2 | 2 | 2 |
| 2014 | 8 | 1 | 4 |
| 2015 | 16 | 1 | 12 |
| 2016 | 15 | 3 | 6 |
| 2017 | 16 | 3 | 9 |
| 2018 | 14 | 1 | 9 |
| 2019 | 9 | 1 | 4 |
| 2020 | 10 | 3 | 4 |
| 2021 | 9 | 0 | 7 |
| 2022 | 7 | 1 | 5 |
| 2023 | 15 | 1 | 8 |
| 2024 | 9 | 0 | 4 |
| 2025 | 1 | 0 | 0 |
What Is MOSAPRIDE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 103 |
| Chronic gastritis | 11 |
| Gastrooesophageal reflux disease | 8 |
| Prophylaxis | 8 |
| Gastritis | 6 |
| Dyspepsia | 5 |
| Nausea | 5 |
MOSAPRIDE vs Alternatives: Which Is Safer?
MOSAPRIDE vs MOSUNETUZUMAB
MOSAPRIDE vs MOSUNETUZUMAB-AXGB
MOSAPRIDE vs MOXIFLOXACIN
MOSAPRIDE vs MOXIFLOXACIN\MOXIFLOXACIN
MOSAPRIDE vs MOXONIDINE
MOSAPRIDE vs MS CONTIN
MOSAPRIDE vs MULTAQ
MOSAPRIDE vs MULTIHANCE
MOSAPRIDE vs MUPIROCIN
MOSAPRIDE vs MUPIROCIN\MUPIROCIN
Official FDA Label for MOSAPRIDE
Official prescribing information from the FDA-approved drug label.